3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
September 13th, 2018
The processes governing bladder cancer invasion represent opportunities for biomarker and therapeutic development. Here we present a bladder cancer invasion model which incorporates 3-D culture of tumor spheroids, time-lapse imaging and confocal microscopy. This technique is useful for defining the features of the invasive process and for screening therapeutic agents.
Overview
This study presents a novel in vitro method to investigate bladder cancer invasion using tumor spheroids. The technique allows for real-time monitoring of the invasive process and facilitates the testing of therapeutic agents.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Cell Biology
Background
- Invasive progression is critical for clinical outcomes in bladder cancer.
- Understanding the mechanisms of invasion can lead to better therapeutic strategies.
- Current methods lack real-time monitoring capabilities.
- Utilizing tumor spheroids can enhance the study of cancer invasion.
Purpose of Study
- To develop a method for studying bladder cancer invasion in vitro.
- To monitor cancer invasion in real-time.
- To evaluate potential therapeutic compounds that inhibit invasion.
Methods Used
- Generation of tumor spheroids from cell lines or primary tumors.
- Embedding spheroids in collagen for structural support.
- Time-lapse imaging to observe invasion dynamics.
- Immunofluorescent staining for detailed analysis post-experiment.
Main Results
- The method successfully allows for real-time observation of invasion.
- Immunofluorescent staining provides insights into cellular interactions.
- Optimization of spheroid formation is crucial for accurate results.
- The technique is adaptable to include various cell types.
Conclusions
- This in vitro model is a valuable tool for studying bladder cancer invasion.
- Real-time monitoring can enhance understanding of invasive mechanisms.
- The approach can facilitate the screening of therapeutic agents.
Frequently Asked Questions
Executive Industry Relevance
Invasive progression in bladder cancer represents a critical inflection point for therapeutic intervention and portfolio triage. This 3-D cell culture system enables real-time, quantitative assessment of tumor invasion and pharmacologic inhibition, directly supporting predictive confidence in early discovery and translational research. The platform's ability to recapitulate the tumor microenvironment enhances mechanistic de-risking and informs risk-adjusted advancement decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of invasion mechanisms and pathway dependencies in a physiologically relevant 3-D context.
- Supports functional target validation by quantifying invasive behavior and molecular marker expression.
- Facilitates mechanistic de-risking by incorporating stromal and immune components to mimic in vivo conditions.
- Provides predictive confidence for portfolio triage by linking molecular changes to invasive phenotypes.
Screening & Assay Development
- Prepares validated 3-D invasion models for limited pharmacologic screening of anti-invasive compounds.
- Delivers reproducible, quantitative outputs via time-lapse imaging and immunofluorescent marker analysis.
- Enables assay standardization and scalability for downstream compound evaluation.
- Supports screening readiness by optimizing spheroid formation and embedding protocols.
Translational & Preclinical Research
- Aligns with disease-relevant systems by modeling the bladder tumor microenvironment and stromal interactions.
- Provides translational continuity from discovery through preclinical validation of anti-invasive strategies.
- Enables biomarker alignment by correlating invasion with EMT markers and pharmacologic response.
- Supports risk-adjusted advancement by generating data on invasion inhibition in a 3-D context.
Pipeline & Workflow Integration
This 3-D invasion assay bridges early discovery, target validation, and preclinical evaluation by providing a unified platform for mechanistic studies and compound screening.
- Discovery Biology: Supports hypothesis testing on invasion drivers and pathway modulation in a controlled 3-D system.
- Screening: Delivers quantitative, reproducible invasion metrics for compound prioritization.
- Analytics: Enables comparative analysis of invasion rates, molecular marker expression, and pharmacologic inhibition.
- Translational Research: Facilitates alignment with in vivo tumor biology and biomarker development.
- Enterprise Reuse: Offers a modular, adaptable platform for diverse tumor types and mechanistic questions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in invasion biology.
- Operational Value: Standardizes 3-D invasion assays for reproducibility and scalability across teams.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by de-risking early-stage assets.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of anti-invasive therapeutic candidates.
Implementation Considerations
- Requires expertise in 3-D cell culture, spheroid formation, and advanced microscopy.
- Demands access to confocal imaging and immunofluorescent staining infrastructure.
- Necessitates cross-team standardization of spheroid and matrix preparation protocols.
- Adaptable to various tumor and stromal cell types for broader disease modeling.
- Limited throughput for large-scale screening; best suited for focused mechanistic and validation studies.
Biopharma FAQs
Chapters in this video
0:04
Title
1:03
Growing Cancer Spheroids
2:24
Preparing the 3D Culture Chamber
3:50
Live Cell Time-lapse Imaging
4:24
Preparation of Sample Block Containing Cancer Spheroids for Frozen Tissue Sectioning
5:36
Immunofluorescence Imaging for Frozen Sectioned Cancer Spheroids
7:18
Results: Invasive Bladder Cancer Tumor Spheroids Formed from Cell Lines and Primary Tumors
8:45
Conclusion
